Assessment of symptoms in COMET-ICE, a phase 2/3 study of sotrovimab for early treatment of non-hospitalized patients with COVID-19

• Main Authors: Sacha Satram (Author), Parima Ghafoori (Author), Carolina M. Reyes (Author), Tom J. H. Keeley (Author), Helen J. Birch (Author), Dimitra Brintziki (Author), Melissa Aldinger (Author), Elizabeth Alexander (Author), Amanda Lopuski (Author), Elias H. Sarkis (Author), Anil Gupta (Author), Adrienne E. Shapiro (Author), John H. Powers (Author)
• Format: Book
• Published: SpringerOpen, 2023-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background The COMET-ICE trial demonstrated that sotrovimab clinically and statistically significantly reduces the risk of all-cause > 24-h hospitalization or death due to any cause among patients with COVID-19 at high risk of disease progression. Patient-reported outcomes are important...